• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 PCR 循环中 DNA 限制的新型方法,用于灵敏和特异性检测 DNA 甲基化生物标志物。

A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling.

机构信息

Epigenomics AG, Berlin, Germany.

出版信息

Biotechniques. 2009 Sep;47(3):737-44. doi: 10.2144/000113208.

DOI:10.2144/000113208
PMID:19852759
Abstract

DNA methylation is an important epigenetic mechanism involved in fundamental biological processes such as development, imprinting, and carcino-genesis. For these reasons, DNA methylation represents a valuable source for cancer biomarkers. Methods for the sensitive and specific detection of methylated DNA are a prerequisite for the implementation of DNA biomarkers into clinical routine when early detection based on the analysis of body fluids is desired. Here, a novel technique is presented for the detection of DNA methylation biomarkers, based on real-time PCR of bisulfite-treated template with enzymatic digestion of background DNA during amplification using the heat-stable enzyme Tsp509I. An assay for the lung cancer methylation biomarker BARHL2 was used to show clinical and analytical performance of the method in comparison with methylation-specific PCR technology. Both technologies showed comparable performance when analyzing technical DNA mixtures and bronchial lavage samples from 75 patients suspected of having lung cancer. The results demonstrate that the approach is useful for sensitive and specific detection of a few copies of methylated DNA in samples with a high background of unmethylated DNA, such as in clinical samples from body fluids.

摘要

DNA 甲基化是一种重要的表观遗传机制,参与发育、印迹和癌变等基本生物学过程。由于这些原因,DNA 甲基化是癌症生物标志物的一个有价值的来源。用于敏感和特异性检测甲基化 DNA 的方法是将 DNA 生物标志物应用于临床常规的前提,当希望基于体液分析进行早期检测时。在这里,提出了一种基于亚硫酸氢盐处理模板的实时 PCR 检测 DNA 甲基化生物标志物的新方法,该方法在扩增过程中使用耐热酶 Tsp509I 酶解背景 DNA。使用肺癌甲基化生物标志物 BARHL2 的测定来比较该方法与甲基化特异性 PCR 技术的临床和分析性能。当分析来自 75 名疑似患有肺癌的患者的技术 DNA 混合物和支气管灌洗样本时,两种技术的性能相当。结果表明,该方法对于从体液等临床样本中检测高背景未甲基化 DNA 中的几个拷贝甲基化 DNA 非常有用。

相似文献

1
A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling.基于 PCR 循环中 DNA 限制的新型方法,用于灵敏和特异性检测 DNA 甲基化生物标志物。
Biotechniques. 2009 Sep;47(3):737-44. doi: 10.2144/000113208.
2
N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.N-Myc下游调控基因4(NDRG4):一种结直肠癌的候选抑癌基因和潜在生物标志物。
J Natl Cancer Inst. 2009 Jul 1;101(13):916-27. doi: 10.1093/jnci/djp131. Epub 2009 Jun 17.
3
Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.正常细胞和癌细胞中未甲基化DNA结构域内差异甲基化位点的鉴定。
Anal Biochem. 2006 Sep 15;356(2):202-7. doi: 10.1016/j.ab.2006.05.019. Epub 2006 Jun 9.
4
Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.甲酰胺作为基因组DNA亚硫酸氢盐转化的变性剂:43例福尔马林固定石蜡包埋前列腺癌标本中GSTPi和RARbeta2基因的亚硫酸氢盐测序
Anal Biochem. 2009 Sep 15;392(2):117-25. doi: 10.1016/j.ab.2009.06.001. Epub 2009 Jun 6.
5
Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease.用于疾病准确分类的结直肠肿瘤特异性甲基化标志物的鉴定与验证
Mol Cancer Res. 2007 Feb;5(2):153-63. doi: 10.1158/1541-7786.MCR-06-0034.
6
Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates.基于支气管抽吸物分析的 SHOX2 基因甲基化生物标志物在肺癌辅助诊断中的性能评估。
Int J Oncol. 2012 Mar;40(3):825-32. doi: 10.3892/ijo.2011.1264. Epub 2011 Nov 16.
7
Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.RAS 关联结构域家族蛋白 1A 的甲基化作为肺癌的生物标志物。
Cancer. 2006 Apr 25;108(2):129-34. doi: 10.1002/cncr.21717.
8
Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.在粪便DNA中检测未表达的波形蛋白基因的结肠癌特异性甲基化。
J Natl Cancer Inst. 2005 Aug 3;97(15):1124-32. doi: 10.1093/jnci/dji204.
9
A real-time PCR assay for DNA-methylation using methylation-specific blockers.一种使用甲基化特异性阻断剂的DNA甲基化实时PCR检测方法。
Nucleic Acids Res. 2004 Jan 13;32(1):e10. doi: 10.1093/nar/gnh008.
10
Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.甲基化富集焦磷酸测序:将甲基化特异性PCR(MSP)的特异性与焦磷酸测序验证相结合。
Nucleic Acids Res. 2006 Jun 28;34(11):e78. doi: 10.1093/nar/gkl424.

引用本文的文献

1
Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.SHOX2 和 SEPT9 基因甲基化与细胞学联合检测对良、交界性和恶性胸腔积液的诊断及预后价值。
PLoS One. 2013 Dec 27;8(12):e84225. doi: 10.1371/journal.pone.0084225. eCollection 2013.
2
Improved PCR performance using template DNA from formalin-fixed and paraffin-embedded tissues by overcoming PCR inhibition.通过克服 PCR 抑制作用,使用来自福尔马林固定和石蜡包埋组织的模板 DNA 提高 PCR 性能。
PLoS One. 2013 Oct 14;8(10):e77771. doi: 10.1371/journal.pone.0077771. eCollection 2013.
3
Restriction enzyme-mediated enhanced detection of circulating cell-free fetal DNA in maternal plasma.
酶切介导增强法检测母体外周血循环游离胎儿 DNA。
J Mol Diagn. 2011 Jul;13(4):382-9. doi: 10.1016/j.jmoldx.2011.02.001. Epub 2011 May 6.
4
Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.肺癌肿瘤中 SHOX2 基因扩增与 DNA 甲基化的相关性。
BMC Cancer. 2011 Mar 22;11:102. doi: 10.1186/1471-2407-11-102.
5
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates.SHOX2 基因启动子区甲基化作为支气管肺泡灌洗液检测标志物用于肺癌的诊断
BMC Cancer. 2010 Nov 3;10:600. doi: 10.1186/1471-2407-10-600.
6
A combined HM-PCR/SNuPE method for high sensitive detection of rare DNA methylation.一种联合 HM-PCR/SNuPE 方法,用于高灵敏度检测罕见的 DNA 甲基化。
Epigenetics Chromatin. 2010 Jun 2;3(1):12. doi: 10.1186/1756-8935-3-12.